FANCL (FA complementation group L) encodes the catalytic E3 ubiquitin ligase subunit of the Fanconi anemia (FA) core complex. As the key catalytic component, FANCL is essential for monoubiquitinating FANCD2 and FANCI, the central activation steps in the FA DNA damage response pathway. Biallelic mutations in FANCL cause Fanconi Anemia type L, characterized by bone marrow failure, congenital abnormalities, and predisposition to cancer.
FANCL (FA complementation group L) encodes the catalytic E3 ubiquitin ligase subunit of the Fanconi anemia (FA) core complex. As the key catalytic component, FANCL is essential for monoubiquitinating FANCD2 and FANCI, the central activation steps in the FA DNA damage response pathway. Biallelic mutations in FANCL cause Fanconi Anemia type L, characterized by bone marrow failure, congenital abnormalities, and predisposition to cancer.
Introduction
The FANCL gene is located on chromosome 2p16.3 and encodes a protein of 380 amino acids. It functions as the E3 ubiquitin ligase within the FA core complex, a multiprotein assembly essential for DNA interstrand crosslink (ICL) repair. The FA pathway is crucial for maintaining genomic stability, and defects in this pathway lead to Fanconi anemia, a rare autosomal recessive disorder characterized by progressive bone marrow failure, developmental abnormalities, and high cancer risk.
Function
FANCL is the catalytic E3 ubiquitin ligase subunit of the Fanconi anemia (FA) core complex. It is responsible for the monoubiquitination of FANCD2 and FANCI, which is the key activation step in the FA DNA repair pathway.
FA Core Complex: Catalytic subunit of the FA core E3 ligase
DNA Damage Response: Activates FA pathway in response to DNA damage
ICL Repair: Essential for interstrand crosslink repair
Disease Associations
Fanconi Anemia: Biallelic FANCL mutations cause FA type L
Breast Cancer: Heterozygous variants may increase risk
Aplastic Anemia: Bone marrow failure in FA
Expression
FANCL is expressed in most tissues:
High in testis, bone marrow
Moderate in brain, breast
Key Publications
[Meetei et al., FANCL is the E3 ligase (2004)](https://doi.org/10.1038/nm1089)
[Alpi et al., FANCL structure and function (2007)](https://doi.org/10.1074/jbc.M7035)
[Zhang & Walter, FA pathway activation (2008)](https://doi.org/10.1016/j.tibs.2008.09.005)
Background
The study of Fancl Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.